伊卢米纳与英国生物银行启动蛋白质组学项目,分析5万个样本,帮助健康研究. Illumina launches proteomics program with UK Biobank to analyze 50,000 samples, aiding health research.

Illuma与英国生物银行和几家制药公司共同启动了一个蛋白质组实验方案,以分析50,000个样本。 Illumina has launched a pilot proteomics program with UK Biobank and several pharmaceutical companies to analyze 50,000 samples. 该方案利用由SOMAmer技术推动的Illuma的蛋白质预科溶液,检测9 000个独特的人类蛋白质,帮助了解蛋白质在健康和疾病中的作用。 The program uses Illumina's Protein Prep solution, powered by SOMAmer technology, to detect 9,000 unique human proteins, aiding in understanding protein roles in health and disease. 这些数据预计将在2025年中期提供,将支持生物标志的发现,并将遗传变异与蛋白质表达方式联系起来,从而有可能推动人类健康研究。 The data, expected to be available mid-2025, will support biomarker discovery and link genetic variation with protein expression, potentially advancing human health research.